Akso Health Group

NASDAQ: AHG · Real-Time Price · USD
1.77
0.03 (1.72%)
At close: Aug 15, 2025, 10:00 AM

Akso Health Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Revenue
2.41M 13.18M 6M 1.75M
Cost of Revenue
2.29M 11.91M 5.39M 544.57K
Gross Profit
122.13K 1.27M 605.13K 1.21M
Operating Income
-8.64M -14.27M -15.13M -27.15M
Interest Income
n/a n/a n/a n/a
Pretax Income
-9.09M -13.07M -16.72M -31.07M
Net Income
-9.46M -13.08M -16.85M -31.55M
Selling & General & Admin
8.76M 15.54M 3.06M 2.09M
Research & Development
n/a -0.99 421.19K 544.57K
Other Expenses
n/a n/a -780.55K -164.92K
Operating Expenses
8.76M 15.54M 16.05M 28.36M
Interest Expense
n/a n/a 804.14K 2.15M
Selling & Marketing Expenses
168.42K 6.66K 391.63K 55.47K
Cost & Expenses
11.05M 27.45M 21.44M 28.9M
Income Tax Expense
24.99K 17.55K 131.43K 482.98K
Shares Outstanding (Basic)
20.81M 7.62M 6.62M 5.43M
Shares Outstanding (Diluted)
23.83M 7.62M 6.62M 5.43M
EPS (Basic)
-0.45 -1.71 -2.55 -5.82
EPS (Diluted)
-0.39 -1.71 -2.55 -5.82
EBITDA
n/a -14.25M -2.44M -2.07M
EBIT
-9.09M -13.07M -3.2M -2.14M
Depreciation & Amortization
138.24K 18.39K 18.39K 15.16K